The phrase "a relevant rate" is correct and usable in written English.
It can be used when discussing a rate that is applicable or significant to a particular context or situation.
Example: "To make an informed decision, we need to consider a relevant rate for the current market conditions."
Alternatives: "an applicable rate" or "a pertinent rate".
The rational to do so is that (additional) carcinogenic effects of test substances can be detected more effectively in rats that develop tumours at a relevant rate within the time span of a 2-year trial.
Moreover, low-dose CT screening is associated with a relevant rate of overdiagnosis and of false positive findings [ 11, 41].
In contrast, bone seekers labelled with a beta emitter can cause a relevant rate of grade-III thrombocytopenia and leucopenia [ 39].
In selected patients, especially if younger than 75, LRRs may be amenable to a multimodal approach that, in a relevant rate of cases, can lead to a potentially curative R0 resection; for the other cases a palliative management is possible, to improve overall survival and quality of life.
These models are in their early developmental stages; a general model for any ligand still needs to be developed that includes all relevant rate constants.
Remodelling increases the off-rate a million-fold relative to that expected for a slip bond, allowing Im9 release and E9 activation at a biologically relevant rate upon binding to a competing organism.
In addition, it should degrade at a physiologically relevant rate.
Given the chemical stability of carbamates formed from 1° and 2° amines, hydrolysis does not occur at an industrially relevant rate, 11 with the exception of heterocyclic secondary amines such as piperidine, which have been demonstrated to form a labile carbamate that is readily hydrolysed.
Analyses were performed using SPSS 18 (IBM, New York, USA), and confidence intervals for all relevant rates were calculated using Confidence Interval Analysis.
Model validations were implemented by a parametrization procedure of relevant rate constants under dynamic simulation fitting to selected experimental time-courses data.
Data from multiple randomized adjuvant trials and observational studies suggest that the rate of discontinuation of trastuzumab treatment ranges between 6 and 31%, mainly due to cardiotoxicity [2 10]; and in patients aged ≥65 years old, this figure increases to a notable and clinically relevant rate of 41%[11]].
